Formula Growth’s Stoneridge SRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-54,000
Closed -$1.12M 140
2022
Q1
$1.12M Buy
+54,000
New +$994K 0.21% 112
2020
Q3
Sell
-175,000
Closed -$3.62M 167
2020
Q2
$3.62M Buy
+175,000
New +$3.28M 0.61% 46

Other funds holding SRI

Formula Growth's SRI Position: Q2 2022 in Review

Formula Growth sold out of Stoneridge (SRI) in Q2 2022, closing a stake of 54,000 shares — an estimated $1.12M sold.

Formula Growth first reported a position in SRI in Q2 2020 and held it in 2 quarters. The position peaked at $3.62M in Q2 2020. 115 funds tracked by Wall St. Rank hold SRI as of Q2 2022.

  • Formula Growth reported no remaining Stoneridge position as of Q2 2022 after selling out during the quarter.
  • Formula Growth sold 54,000 Stoneridge shares in Q2 2022, an estimated $1.12M.
  • Formula Growth first reported a position in Stoneridge in Q2 2020 and held it in 2 quarters.
  • Formula Growth's Stoneridge position peaked at $3.62M in Q2 2020.
  • 115 funds tracked by Wall St. Rank held Stoneridge as of Q2 2022.

Based on Formula Growth's 13F filing for Q2 2022, filed 12 Aug 2022.